Dr. Schachter specializes in ocular surface disease and serves as a Vision Source administrator for central California coast. He serves on the advisory board for Allergan, BlephEx, Sun Pharma, and ScienceBased Health, and he is a speaker for Allergan, Bau
Scott Schachter, OD, reviews the The Tear Film and Ocular Surface Society's (TFOS) 2020 virtual meeting, which hosted global speakers presenting research on challenges and unmet needs of managing, diagnosing and treating ocular surface disease in their regions.
